FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/077249 [Registered on: 25/11/2024] Trial Registered Prospectively
Last Modified On: 05/09/2025
Post Graduate Thesis  No 
Type of Trial  PMS 
Type of Study   Nutraceutical 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect of Cosmix No Nonsense Plant Protein on Muscles gain and weight loss  
Scientific Title of Study   A double blind Randomized clinical study to study the effect of Cosmix No Nonsense Plant Protein on Muscles gain and weight loss on subjects with Muscle Training 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
CCFT 391 Version 1.0 dated 30 Oct 2024  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Gaurav Gupta 
Designation  Principal Investigator 
Affiliation  CCFT Laboratories 
Address  2nd Floor room 2, Sports Rehab Area, CCFT laboratories, AR multispecialty hospital and research center, Delhi Road

Meerut
UTTAR PRADESH
250002
India 
Phone  9810799698  
Fax    
Email  dr.gpmc@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Puneet Mittal 
Designation  Clinical Research Consultant 
Affiliation  CCFT Laboratories 
Address  1st Floor room 3, Skin testing lab , CCFT laboratories, AR multispecialty hospital and research center, Delhi Road

Meerut
UTTAR PRADESH
250002
India 
Phone  8937015757  
Fax    
Email  puneetmittal@mgcts.org  
 
Details of Contact Person
Public Query
 
Name  Puneet Mittal 
Designation  Clinical Research Consultant 
Affiliation  CCFT Laboratories 
Address  1st Floor room 3, Skin testing lab , CCFT laboratories, AR multispecialty hospital and research center, Delhi Road

Meerut
UTTAR PRADESH
250002
India 
Phone  8937015757  
Fax    
Email  puneetmittal@mgcts.org  
 
Source of Monetary or Material Support  
CCFT Laboratories, 135, Punjabipura, Delhi Road, Meerut, India, 250002  
 
Primary Sponsor  
Name  Cosmix Wellness Pvt Ltd 
Address  215/2, S3 Harohalli industrial area, Kanak pura Road, Ramnagar-502112 
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor  
Name  Address 
Not Applicable  Not Applicable 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Gaurav Gupta  CCFT laboratories  2sd Floor room 2, Rehab Area, CCFT laboratories, AR multispecialty hospital and research center, Delhi Road
Meerut
UTTAR PRADESH 
9810799698

dr.gpmc@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
ARMHRC Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Not Applicable 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Test Product: Cosmix No Nonsense Plant Protein with Enzymes  Test Product: Cosmix No Nonsense Plant Protein, Dose: 1 scope per day 30 minutes post Exercise, Rout of Administration: Oral, Duration: 28 Days 
Comparator Agent  Test Product: Cosmix No Nonsense Plant Protein without Enzymes   Test Product: Cosmix No Nonsense Plant Protein, Dose: 1 scope per day 30 minutes post Exercise, Rout of Administration: Oral, Duration: 28 Days 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1) Gender: Male or Female 18 to 50
2) Subjects willing to give written informed consent
3) Women of child bearing potential must have a negative urine pregnancy test prior to study entry.
4) Are free of any systemic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events.
5) Are willing to join the training program throughout the study duration. 
 
ExclusionCriteria 
Details  1. Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study.
2. Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.
3. Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product.
4. Have participated in any interventional clinical trial in the previous 90 days.
5. Have a known sensitivity to any of the constituents of the test product including sensitivities to any ingredient
6. Have used, are using, or are planning to use
immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Pre-numbered or coded identical Containers 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
Change in Muscle Thickness  Day 0, Day 28 
 
Secondary Outcome  
Outcome  TimePoints 
Change in Body Fat  Day 0, Day 28 
Change in the weight  Day 0, Day 28 
Change in the Resting Metabolism  Day 0, Day 28 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="0" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   04/12/2024 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
A single arm registered clinical study
Assessments
 Muscle Measurement- Hamstring, Biceps, Chest with circumference measure
 Bioelectrical impedance analysis BIA for Body fat, and resting metabolism
 Subject’s Assessment Questionnaire for digestion, AE’s, Taste, Ease of Use, etc, as % users experienced X parameter.
Assessment timepoints: 4 weeks

 
Close